Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA single nuclei brain specificity"	"RNA single nuclei brain distribution"	"RNA single nuclei brain specificity score"	"RNA single nuclei brain specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Secretome function"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Brain expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	Interactions	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (validation)"	"Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (validation)"	"Cancer prognostics - Glioblastoma Multiforme (TCGA)"	"Cancer prognostics - Glioblastoma Multiforme (validation)"	"Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Chromophobe (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)"	"Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (validation)"	"Cancer prognostics - Lung Adenocarcinoma (TCGA)"	"Cancer prognostics - Lung Adenocarcinoma (validation)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (validation)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)"	"Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)"	"Cancer prognostics - Pancreatic Adenocarcinoma (validation)"	"Cancer prognostics - Prostate Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (validation)"	"Cancer prognostics - Skin Cuteneous Melanoma (TCGA)"	"Cancer prognostics - Stomach Adenocarcinoma (TCGA)"	"Cancer prognostics - Testicular Germ Cell Tumor (TCGA)"	"Cancer prognostics - Thyroid Carcinoma (TCGA)"	"Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)"
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"brain: 240.4"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 145.9;Enteroendocrine cells: 228.5;Excitatory neurons: 307.8;Horizontal cells: 429.9;Inhibitory neurons: 356.4;Oligodendrocyte precursor cells: 255.2"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 6.5"	"Region enhanced"	"Detected in all"		"cerebellum: 218.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 5.2;lung cancer: 8.4;Rhabdoid: 8.2"	"Pancreas - Alpha cells, Pancreas - Beta cells, Skeletal muscle - Smooth muscle cells, Stomach - Gastric enteroendocrine cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 2: Neurons - Nucleosome"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	41	"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (6.25e-2)"		"unprognostic (1.87e-2)"				"unprognostic (8.10e-2)"	"potential prognostic favorable (2.58e-4)"												"unprognostic (1.10e-2)"	"unprognostic (6.23e-2)"	"potential prognostic favorable (8.21e-6)"	"unprognostic (2.93e-2)"				"unprognostic (1.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.19e-2)"
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 22.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 375.5;Inhibitory neurons: 316.8"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 14.3"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044347	Uncertain		Approved	"Cytosol,Acrosome,Equatorial segment"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	3	"Cytosol, Acrosome, Equatorial segment"		"HPA044347: AB_10960837"			"unprognostic (4.29e-2)"					"unprognostic (5.93e-3)"										"unprognostic (1.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.50e-2)"									"unprognostic (1.57e-1)"		
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970772-2697950	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;heart muscle: 20.2;intestine: 28.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 586.4;Inhibitory neurons: 456.6;Oligodendrocyte precursor cells: 182.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 3.9"	"Prostate - Smooth muscle cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Primary cilium"			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 34: Neurons - Neuronal signaling"	28	"Nucleoplasm, Plasma membrane"	"Primary cilium"	"CAB079031: , HPA039796: AB_10673019"	"unprognostic (3.73e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.20e-2)"			"unprognostic (8.22e-2)"		"unprognostic (1.22e-3)"			"validated prognostic favorable (1.04e-4)"	"validated prognostic favorable (4.50e-4)"					"unprognostic (3.90e-1)"		"unprognostic (2.10e-2)"			"unprognostic (1.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.39e-2)"		"unprognostic (8.77e-3)"		"unprognostic (2.07e-2)"	"unprognostic (1.10e-1)"		
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 242.8;Horizontal cells: 112.0;Inhibitory neurons: 339.0;Microglial cells: 120.8;Oligodendrocyte precursor cells: 185.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 3.7"	"Low cancer specificity"	"Detected in many"			"Breast - Breast glandular cells, Skeletal muscle - Fibroblasts, Spleen - Fibroblast_2, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"			NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 64: Neuronal - Transcription"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"		"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.50e-2)"		"unprognostic (3.32e-2)"	"unprognostic (8.32e-2)"		"unprognostic (7.08e-3)"		"unprognostic (2.66e-1)"	"potential prognostic favorable (1.69e-8)"	"unprognostic (3.49e-3)"	"unprognostic (1.34e-2)"		"unprognostic (1.57e-1)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-2)"					"unprognostic (7.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"			
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181813262	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 182.2;Inhibitory neurons: 110.6;Oligodendrocyte precursor cells: 69.3;Oligodendrocytes: 31.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4;lung cancer: 2.0"	"Colon - Colon enteroendocrine cells, Kidney - Proximal tubular cells, Lung - Neutrophil_2, Spleen - Neutrophils, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 34: Neurons - Neuronal signaling"		"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "							"unprognostic (3.10e-1)"	"potential prognostic favorable (5.61e-5)"			"unprognostic (1.36e-2)"	"unprognostic (8.10e-3)"								"unprognostic (8.88e-3)"						"unprognostic (1.22e-1)"		"unprognostic (3.72e-2)"	"unprognostic (3.23e-2)"		
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"retina: 121.4"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 66.4;Cone photoreceptor cells: 73.1;Rod photoreceptor cells: 91.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in single"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced						NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 76: Retina - Visual perception"	"Cluster 48: Non-specific - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 66: Photoreceptor cells - Visual perception"				"HPA068379: AB_2732782"			"unprognostic (3.99e-2)"			"unprognostic (8.06e-2)"						"unprognostic (1.02e-2)"					"unprognostic (3.60e-2)"			"unprognostic (3.59e-1)"						"unprognostic (2.01e-2)"					"unprognostic (1.82e-1)"
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50560715-50627474	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.5;cervix: 9.5;retina: 8.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 152.8;Horizontal cells: 68.0"	"Cell type enhanced"	"Detected in many"		"midbrain-derived inhibitory: 132.5;thalamic excitatory: 98.5"	"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 3.8;Testicular Germ Cell Tumor (TCGA): 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 6.8"	"Lung - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol,Acrosome,Equatorial segment,Perinuclear theca"			NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"		"Nucleoplasm, Acrosome, Equatorial segment, Perinuclear theca"	"Nuclear bodies, Cytosol"	"HPA004714: AB_1078368"			"unprognostic (2.08e-1)"				"unprognostic (2.02e-1)"	"unprognostic (3.20e-2)"																"unprognostic (2.05e-1)"		"unprognostic (5.70e-2)"			"unprognostic (4.51e-2)"		
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153106-1221771	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.0;Enteroendocrine cells: 13.1;Horizontal cells: 12.0;Late spermatids: 14.5;Ovarian stromal cells: 17.9;Peritubular cells: 22.7;Smooth muscle cells: 28.7"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 36.6;vascular associated smooth muscle cell: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Adrenal gland - Adrenal cortex cells, Minor Salivary Gland - Endothelial cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039125	Approved		Approved	Nucleoplasm,Vesicles			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 33: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 48: Smooth muscle cells - Signal transduction"	2	"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (3.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.13e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-2)"	"potential prognostic unfavorable (9.56e-5)"	"unprognostic (1.26e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.93e-3)"		"unprognostic (8.97e-2)"	"unprognostic (1.05e-2)"	"potential prognostic favorable (2.72e-5)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.90e-1)"
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689735	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;thyroid gland: 5.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.5;Excitatory neurons: 16.3;Horizontal cells: 30.2;Inhibitory neurons: 11.7"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	5	"Thyroid Carcinoma (TCGA): 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 2.8;Rhabdoid: 1.3"	"Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066992			Approved	"Plasma membrane,Cell Junctions,Acrosome"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 24: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	2	"Plasma membrane"	"Cell Junctions, Acrosome"	"HPA066992: "			"unprognostic (1.71e-1)"																											"unprognostic (1.64e-2)"	
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112451	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"skeletal muscle: 245.8;tongue: 185.7"	"Cell type enriched"	"Detected in some"	15	"Skeletal myocytes: 106.4"	"Cell type enhanced"	"Detected in some"		"vascular associated smooth muscle cell: 5.7"	"Cancer enriched"	"Detected in single"	5	"Head and Neck Squamous Cell Carcinoma (TCGA): 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Adipose visceral - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Testis - Late spermatids"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 3.8"	"CAB009507, HPA048892, HPA056815"	Enhanced		Approved	"Acrosome,Equatorial segment"			NA	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 2: Skeletal myocytes - Muscle contraction"	4	"Acrosome, Equatorial segment"		"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"									"unprognostic (1.22e-2)"																						
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.4;testis: 15.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.6;Early spermatids: 75.3;Horizontal cells: 40.9;Rod photoreceptor cells: 171.5;Spermatocytes: 65.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042709			Uncertain	"Vesicles,Plasma membrane,Primary cilium,Principal piece,End piece"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 39: Retina & Testis - Cilium"	"Cluster 2: Neurons - Nucleosome"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 66: Photoreceptor cells - Visual perception"	1	"End piece"	"Vesicles, Plasma membrane, Primary cilium, Principal piece"	"HPA042709: "	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.28e-2)"		"unprognostic (3.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.56e-1)"		"unprognostic (2.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.95e-3)"	"unprognostic (3.89e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"		"unprognostic (1.58e-2)"	"unprognostic (2.30e-1)"
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	53	"testis: 10.9"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 90.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced						NA	NA				"Cluster 42: Testis - Spermatogenesis"			"Cluster 18: Early spermatids - Unknown function"	1			"HPA045257: AB_10968995"																															
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport, Vision"	"Calcium channel, Ion channel, Ligand-gated ion channel, Sodium channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 256.4"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 908.7"	"Cell type enhanced"	"Detected in many"		"pericyte: 67.8;vascular associated smooth muscle cell: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA076168			Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Mitotic spindle,Primary cilium,Primary cilium tip,Mid piece,Principal piece"			Yes	NA				"Cluster 76: Retina - Visual perception"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 66: Photoreceptor cells - Visual perception"		"Nucleoplasm, Vesicles, Mid piece, Principal piece"	"Plasma membrane, Mitotic spindle, Primary cilium, Primary cilium tip"	"HPA076168: AB_2686781"	"unprognostic (1.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.01e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.79e-1)"			"unprognostic (1.59e-2)"	"unprognostic (4.25e-2)"	"potential prognostic favorable (5.64e-5)"			"unprognostic (6.55e-2)"	"unprognostic (5.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.91e-2)"		"unprognostic (6.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.36e-2)"		"unprognostic (2.19e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.43e-2)"
CNGA2	"CNCA, CNCA1, CNG2, FLJ46312, OCNC1, OCNCa, OCNCALPHA"	ENSG00000183862	"Cyclic nucleotide gated channel subunit alpha 2"	Q16280	X	151734746-151745564	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Olfaction, Sensory transduction, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Sertoli cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015065	Uncertain						NA	NA						"Cluster 11: Neuronal - Sensory perception"					"HPA015065: AB_1847034"																															
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel subunit alpha 3"	Q16281	2	98346188-98398601	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport, Vision"	"Calcium channel, Ion channel, Ligand-gated ion channel, Sodium channel"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 4.8;intestine: 4.1;pituitary gland: 9.9;retina: 5.7"	"Cell type enriched"	"Detected in some"	11	"Cone photoreceptor cells: 34.0"	"Cell type enhanced"	"Detected in some"		"astrocyte: 11.5;choroid plexus epithelial cell: 10.8;ependymal cell: 10.5"	"Cancer enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 15.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"Neuroblastoma: 1.5"	"Lung - Respiratory ciliated cells, Pancreas - Alpha cells, Pancreas - Beta cells, Testis - Early spermatids"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.8;hypothalamus: 1.9"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved	Approved	"Mid piece,Principal piece,End piece"			NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 22: Non-specific - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 66: Photoreceptor cells - Visual perception"	1	"Mid piece, Principal piece, End piece"		"CAB079025: , HPA049378: AB_2732551"			"unprognostic (2.37e-1)"				"unprognostic (9.01e-2)"	"potential prognostic unfavorable (3.80e-4)"								"potential prognostic favorable (4.79e-4)"	"unprognostic (1.34e-1)"														
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel subunit alpha 4"	Q8IV77	11	6234765-6244479	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Olfaction, Sensory transduction, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 16.7;testis: 5.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.7;Ciliated cells: 2.2;Early spermatids: 5.2;Excitatory neurons: 2.9;Inhibitory neurons: 2.5;Late spermatids: 4.5;Oligodendrocytes: 2.8"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 20.8"	"Cancer enriched"	"Detected in single"	4	"Uterine Corpus Endometrial Carcinoma (TCGA): 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA074128			Uncertain	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 59: Fallopian tube - Tissue development"	"Cluster 46: Brainstem - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 47: Astrocytes - Unknown function"	10	"Nucleoplasm, Plasma membrane"		"HPA074128: "			"unprognostic (1.42e-1)"																												"unprognostic (7.55e-2)"
CNGB3	"ACHM1, ACHM3, RMCH"	ENSG00000170289	"Cyclic nucleotide gated channel subunit beta 3"	Q9NQW8	8	86553977-86743675	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.1;retina: 12.1"	"Cell type enriched"	"Detected in some"	22	"Cone photoreceptor cells: 249.8"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Thyrotropes, Testis - Early spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA057244	Enhanced						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 31: Non-specific - Transcription"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 66: Photoreceptor cells - Visual perception"				"HPA057244: AB_2683380"						"unprognostic (1.45e-3)"																				"unprognostic (5.81e-2)"					
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254948-45696498	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 17.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 649.4;Inhibitory neurons: 735.4;Rod photoreceptor cells: 197.6"	"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Rhabdoid: 1.4"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pituitary gland - Corticotropes, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 53: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 8: Neurons - Neuronal signaling"	17			"HPA019195: AB_2670094"								"unprognostic (2.00e-1)"																							
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589881-617159	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ammonia transport, Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 100.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 54.6;Horizontal cells: 27.7;Inhibitory neurons: 18.0;Oligodendrocytes: 57.7;Oocytes: 27.2"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 128.2"	"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 35.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 13.4"	"Colon - Colon enteroendocrine cells, Heart muscle - Cardiomyocytes, Pancreas - Alpha cells, Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 18: Non-specific - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 25: Bipolar cells - Visual perception"	2						"unprognostic (5.90e-2)"				"unprognostic (7.98e-2)"	"unprognostic (7.60e-3)"		"unprognostic (4.72e-2)"			"unprognostic (5.20e-2)"									"unprognostic (5.32e-3)"					"unprognostic (7.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.26e-1)"		
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277463-155289848	"Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7;liver: 14.3"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 6.0;Inhibitory neurons: 9.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved						NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 1: Neurons - Mixed function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 69: Neurons - Neuronal signaling"	1			"HPA026584: AB_1850534"			"unprognostic (1.15e-1)"		"unprognostic (1.76e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"potential prognostic favorable (2.74e-5)"				"unprognostic (1.68e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.52e-1)"					"unprognostic (2.48e-1)"	"unprognostic (2.84e-1)"		"unprognostic (1.25e-3)"			"unprognostic (2.37e-1)"		"unprognostic (3.45e-2)"			
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 8.1;testis: 7.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 16.8;Late spermatids: 53.8"	"Cell type enhanced"	"Detected in many"		"midbrain-derived inhibitory: 26.4"	"Cancer enriched"	"Detected in single"	5	"Testicular Germ Cell Tumor (TCGA): 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 1.8"	"Adrenal gland - Adrenal medulla cells, Lung - Respiratory ciliated cells, Pituitary gland - Gonadotropes, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved						NA	NA				"Cluster 44: Testis - Spermatogenesis"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 11: Late spermatids - Unknown function"	5			"HPA073174: "																													"unprognostic (6.74e-2)"		
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909905-4918256	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"brain: 52.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Excitatory neurons: 38.3;Horizontal cells: 21.4;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 15.1"	"Cell type enhanced"	"Detected in some"		"upper rhombic lip: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"lung cancer: 2.5"	"Pituitary gland - Thyrotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	18			"HPA074471: "								"unprognostic (2.28e-2)"																							
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA						"Cluster 11: Neuronal - Sensory perception"		6																																		
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 32.1;retina: 9.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 47.4;Early spermatids: 16.9;Excitatory neurons: 35.5;Horizontal cells: 33.4;Inhibitory neurons: 35.6;Muller glia cells: 15.6;Oligodendrocyte precursor cells: 34.0"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"Glioblastoma Multiforme (TCGA): 3.9;Skin Cuteneous Melanoma (TCGA): 1.1;Testicular Germ Cell Tumor (TCGA): 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Group enriched"	"Detected in some"	5	"Bone cancer: 8.0;Myeloma: 3.0"	"Colon - Enteric glia cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced						NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 8: Neurons - Neuronal signaling"	13			"CAB001976: "							"unprognostic (1.35e-1)"	"unprognostic (8.14e-2)"											"unprognostic (4.55e-1)"								"unprognostic (3.11e-2)"		"unprognostic (3.44e-1)"		
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110653560-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.9;lung: 2.1;lymphoid tissue: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 12.7;Inhibitory neurons: 57.6;Plasma cells: 49.8;T-cells: 24.0"	"Cell type enhanced"	"Detected in some"		"leukocyte: 6.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.6;MAIT T-cell: 5.3;memory CD4 T-cell: 8.5;memory CD8 T-cell: 9.6;naive B-cell: 2.6;naive CD4 T-cell: 5.0;naive CD8 T-cell: 4.6;T-reg: 8.5"	"Group enriched"	"Detected in many"	6	"B-cells: 2.6;T-cells: 9.6"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 5.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Minor Salivary Gland - Plasma cells, Skin - T-cells, Testis - Spermatocytes, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved						NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 1: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 7: T-cells - T-cell receptor"	102			"HPA016625: AB_2669407"			"unprognostic (7.90e-2)"			"unprognostic (1.03e-1)"		"unprognostic (4.85e-2)"				"unprognostic (2.23e-2)"				"unprognostic (8.41e-3)"	"unprognostic (1.07e-3)"		"unprognostic (4.17e-1)"				"unprognostic (1.42e-1)"			"unprognostic (7.88e-2)"		"unprognostic (4.08e-2)"	"unprognostic (2.81e-2)"		
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4, PCN2"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.9;brain: 7.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.7;Cardiomyocytes: 3.5;Excitatory neurons: 7.9;Horizontal cells: 6.9;Mesothelial cells: 6.8;Muller glia cells: 3.9"	"Cell type enhanced"	"Detected in many"		"mammillary body: 57.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal cortex cells, Colon - Colon enteroendocrine cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001977, HPA016422"	Approved						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 33: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	13			"CAB001977: , HPA016422: AB_1855574"								"unprognostic (1.86e-3)"																							
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 59.0;heart muscle: 38.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 128.0;Cardiomyocytes: 21.5;dendritic cells: 18.9;Horizontal cells: 34.0;Smooth muscle cells: 29.1"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 14.0;ependymal cell: 14.6;vascular associated smooth muscle cell: 38.9"	"Cancer enhanced"	"Detected in some"		"Pancreatic Adenocarcinoma (TCGA): 3.1"	"Region enriched"	"Detected in all"	7	"choroid plexus: 113.8"	"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cancer enriched"	"Detected in single"	6	"Leukemia: 1.8"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Pancreas - Alpha cells, Pancreas - Beta cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021516, CAB022562"	Approved						NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 25: Bipolar cells - Visual perception"	14			"CAB022562: , HPA021516: AB_2670732"			"unprognostic (2.26e-1)"					"unprognostic (1.91e-1)"			"unprognostic (1.99e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.29e-2)"									"unprognostic (2.23e-2)"							"unprognostic (2.03e-1)"		
KCNA6	"HBK2, Kv1.6, PPP1R96"	ENSG00000151079	"Potassium voltage-gated channel subfamily A member 6"	P17658	12	4809334-4813318	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 9.4"	"Group enriched"	"Detected in some"	8	"Astrocytes: 13.3;Excitatory neurons: 26.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 20.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 4.6;Testicular Germ Cell Tumor (TCGA): 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Leukemia: 2.3;testis cancer: 7.8"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076475			Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 8: Neurons - Neuronal signaling"	8	"Plasma membrane, Cytosol"	Vesicles	"HPA076475: "			"unprognostic (2.00e-1)"				"unprognostic (2.27e-1)"	"unprognostic (4.51e-2)"																					"unprognostic (1.67e-1)"		
KCNA7	"HAK6, Kv1.7"	ENSG00000104848	"Potassium voltage-gated channel subfamily A member 7"	Q96RP8	19	49067397-49072699	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	53	"skeletal muscle: 76.8;tongue: 19.8"	"Cell type enriched"	"Detected in some"	33	"Skeletal myocytes: 57.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Gonadotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075990			Approved	"Vesicles,Plasma membrane"			NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 6: Non-specific - Immune response"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 2: Skeletal myocytes - Muscle contraction"		"Vesicles, Plasma membrane"		"HPA075990: "																							"unprognostic (1.53e-2)"			"potential prognostic favorable (3.83e-4)"					
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Exocytosis, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 111.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.9;Cone photoreceptor cells: 309.2;Excitatory neurons: 145.6;Inhibitory neurons: 85.9;Rod photoreceptor cells: 352.3"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 3.5;Rhabdoid: 4.0"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Pituitary gland - Thyrotropes, Prostate - Smooth muscle cells, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001979, HPA042434"	Enhanced						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 53: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 66: Photoreceptor cells - Visual perception"	8			"CAB001979: , HPA042434: AB_2677996"			"unprognostic (1.80e-1)"				"unprognostic (2.86e-1)"	"potential prognostic favorable (7.76e-7)"				"unprognostic (4.95e-2)"		"unprognostic (7.89e-2)"												"unprognostic (2.76e-2)"		"unprognostic (1.39e-3)"			
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;lymphoid tissue: 2.2;retina: 4.4"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 178.4;Excitatory neurons: 269.5;Inhibitory neurons: 230.5"	"Cell type enhanced"	"Detected in all"		"miscellaneous: 1482.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.8"	"Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells, Testis - Late spermatids"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"			Yes	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 14: Neurons - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 69: Neurons - Neuronal signaling"	2	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"								"unprognostic (3.13e-2)"																							
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 102.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Excitatory neurons: 46.6;Horizontal cells: 272.6;Inhibitory neurons: 115.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.3;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 7.7"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pituitary gland - Corticotropes, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	2	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "		"unprognostic (3.33e-2)"	"unprognostic (3.85e-1)"			"unprognostic (2.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"																		"unprognostic (5.10e-2)"			"unprognostic (1.18e-1)"		
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209839	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.8"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 377.2;Inhibitory neurons: 1368.9"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 2159.6;MGE interneuron: 1938.6"	"Group enriched"	"Detected in some"	8	"Breast Invasive Carcinoma (TCGA): 5.6;Prostate Adenocarcinoma (TCGA): 14.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.2;Sarcoma: 1.0"	"Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 65: Neurons - Synaptic function"				"CAB022571: , HPA019664: AB_1855578"		"unprognostic (3.60e-1)"	"unprognostic (1.80e-1)"				"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"							"unprognostic (1.60e-1)"									"unprognostic (1.30e-1)"							
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.2;thyroid gland: 50.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 19.4;Excitatory neurons: 15.1;Glandular and luminal cells: 14.9;Inhibitory neurons: 17.6;monocytes: 16.5;Secretory cells: 19.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Spleen - Macrophages, Stomach - Gastric enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 37: Glandular & Luminal cells - Unknown function"	11			"HPA018041: AB_1855579"	"unprognostic (3.29e-3)"	"unprognostic (1.12e-1)"	"potential prognostic favorable (1.67e-4)"	"unprognostic (2.05e-1)"		"unprognostic (3.70e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.10e-2)"	"potential prognostic unfavorable (3.45e-4)"		"unprognostic (8.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.63e-2)"
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110210314-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.5"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 43.2;Sertoli cells: 29.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary gland ductal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol			NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 24: Neurons - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	1	"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (1.04e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.41e-3)"	"unprognostic (3.71e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-1)"	"potential prognostic favorable (9.91e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.03e-2)"		"unprognostic (5.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.42e-2)"
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 2.4;Peritubular cells: 4.0;Rod photoreceptor cells: 4.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm			Yes	No				"Cluster 28: Neuronal - Transcription"	"Cluster 25: Non-specific - Transcription"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 53: Fibroblasts - ECM organization"		Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.20e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"			"potential prognostic unfavorable (1.19e-5)"	"unprognostic (1.64e-2)"	"unprognostic (9.18e-3)"			"unprognostic (6.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"potential prognostic unfavorable (2.88e-4)"	"unprognostic (1.48e-1)"	"potential prognostic favorable (3.21e-5)"	"unprognostic (8.48e-3)"			"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.44e-2)"
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273175-120750337	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 36.3"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 667.4;Inhibitory neurons: 1026.1;Oligodendrocyte precursor cells: 1832.4"	"Cell type enhanced"	"Detected in all"		"midbrain-derived inhibitory: 5323.0;upper rhombic lip: 5357.6"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 12.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.9"	"Pituitary gland - Lactotropes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 8: Neurons - Neuronal signaling"	11			"HPA029068: AB_10601436"	"unprognostic (3.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-2)"				"unprognostic (3.55e-1)"	"potential prognostic favorable (2.04e-5)"								"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-2)"	"unprognostic (5.03e-2)"								
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989668	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.6;Cardiomyocytes: 36.9;Excitatory neurons: 102.1;Hepatocytes: 32.7;Horizontal cells: 40.9;Inhibitory neurons: 84.6;Late spermatids: 34.4;Oligodendrocyte precursor cells: 42.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 1.6"	"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved						NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	4			"HPA029452: AB_10602239"	"unprognostic (2.39e-3)"	"unprognostic (9.43e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.94e-1)"		"unprognostic (1.68e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.82e-1)"		"unprognostic (4.59e-3)"	"unprognostic (9.59e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.55e-2)"	"unprognostic (9.48e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.50e-1)"		"unprognostic (3.62e-1)"			
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	29	"brain: 46.8;choroid plexus: 24.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.0;Extravillous trophoblasts: 17.6;Inhibitory neurons: 8.4;Oligodendrocyte precursor cells: 17.0;Syncytiotrophoblasts: 7.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	7	"Glioblastoma Multiforme (TCGA): 46.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 11.5;lung cancer: 9.0"	"Breast - Breast glandular cells (progenitors), Pancreas - Beta cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Primary cilium transition zone"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 69: Neurons - Neuronal signaling"	9	"Golgi apparatus"	"Nucleoplasm, Vesicles, Primary cilium transition zone"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-1)"				"unprognostic (9.72e-2)"	"unprognostic (6.57e-2)"			"potential prognostic favorable (9.92e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.11e-1)"							"unprognostic (5.33e-2)"	"unprognostic (8.49e-2)"							"unprognostic (3.43e-3)"	"unprognostic (1.29e-1)"		
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023107	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"endometrium 1: 84.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 51.0;Early spermatids: 19.2;Late spermatids: 21.2;Syncytiotrophoblasts: 82.4"	"Cell type enhanced"	"Detected in many"		"amygdala excitatory: 48.3"	"Cancer enriched"	"Detected in many"	4	"Bladder Urothelial Carcinoma (TCGA): 48.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"naive B-cell: 7.1"	"Lineage enriched"	"Detected in single"	72	"B-cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal medulla cells, Heart muscle - Fibroblasts, Minor Salivary Gland - Minor salivary gland basal cells, Testis - Sertoli cells"	"Group enriched"	"Detected in many"	5	"amygdala: 20.6;basal ganglia: 19.1;cerebral cortex: 14.9;hippocampal formation: 18.1;white matter: 9.1"	"Group enriched"	"Detected in all"	5	"amygdala: 17.3;basal ganglia: 15.0;cerebral cortex: 29.9;hippocampal formation: 22.6"	"HPA039530, HPA040024"	Approved		Approved	Vesicles			NA	NA			"Cluster 34: B-cells - Unknown function"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 14: Neurons - Synaptic function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 24: Cytotrophoblasts - Mitochondria"		Vesicles		"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.16e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.87e-3)"	"potential prognostic unfavorable (7.47e-4)"	"unprognostic (2.18e-1)"		"unprognostic (8.65e-2)"						"unprognostic (1.05e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"potential prognostic unfavorable (1.20e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.68e-1)"		"unprognostic (1.59e-1)"
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79797938-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.0;Excitatory neurons: 18.6;Horizontal cells: 27.1;Inhibitory neurons: 29.9;Oocytes: 75.0"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 24.5"	HPA048628	Enhanced						NA	NA				"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 29: Forebrain - Mixed function"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 69: Neurons - Neuronal signaling"				"HPA048628: AB_2680466"			"unprognostic (3.27e-2)"																												
KCNG3	Kv6.3	ENSG00000171126	"Potassium voltage-gated channel modifier subfamily G member 3"	Q8TAE7	2	42442017-42493982	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 15.8;Glandular and luminal cells: 10.8"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 88.1;hippocampal dentate gyrus: 82.0;upper-layer intratelencephalic: 55.3"	"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 1.6;Testicular Germ Cell Tumor (TCGA): 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"Rhabdoid: 7.1"	"Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041625			Approved	"Cytoplasmic bodies"			NA	NA				"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 51: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 34: Neurons - Neuronal signaling"	1	"Cytoplasmic bodies"		"HPA041625: "			"unprognostic (1.29e-1)"					"unprognostic (4.22e-3)"																"unprognostic (2.33e-1)"					"unprognostic (2.36e-1)"		
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218657-84240012	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"retina: 3.8"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 57.8"	"Cell type enriched"	"Detected in some"	13	"oligodendrocyte precursor cell: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal medulla cells, Minor Salivary Gland - Minor salivary glandular cells"	"Group enriched"	"Detected in all"	4	"cerebellum: 90.5;pons and medulla: 27.0"	"Low region specificity"	"Detected in many"			HPA063516			Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	2	"Plasma membrane"	Nucleoplasm	"HPA063516: "																															
KCNH1	"eag, eag1, h-eag, hEAG, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134165	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 16.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 516.4;Inhibitory neurons: 249.8;Oligodendrocytes: 108.5"	"Cell type enhanced"	"Detected in all"		"hippocampal dentate gyrus: 338.3;upper-layer intratelencephalic: 317.5"	"Cancer enhanced"	"Detected in some"		"Breast Invasive Carcinoma (TCGA): 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	4	"Adrenocortical cancer: 20.7"	"Skin - Outer root sheath cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014551, HPA019445, HPA076421"	Enhanced		Approved	Vesicles			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 34: Neurons - Neuronal signaling"	6	Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "		"unprognostic (1.11e-1)"	"unprognostic (2.74e-2)"				"unprognostic (2.15e-1)"	"potential prognostic favorable (1.96e-5)"																			"unprognostic (1.92e-2)"				
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978321	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.8;pituitary gland: 42.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 209.8;Cardiomyocytes: 80.3;Erythroid cells: 116.1;granulocytes: 43.3;Horizontal cells: 57.3;Sertoli cells: 65.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Leukemia: 23.5;Neuroblastoma: 41.8"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Lung - Fibroblast_1, Pancreas - Alpha cells, Pancreas - Beta cells, Prostate - Smooth muscle cells, Skin - Smooth muscle cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	11				"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.84e-1)"		"unprognostic (9.34e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.61e-3)"		"unprognostic (3.93e-2)"	"potential prognostic favorable (3.21e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.68e-2)"		"unprognostic (5.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.08e-2)"		"unprognostic (9.69e-2)"	"unprognostic (6.13e-2)"		"unprognostic (5.49e-2)"
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539030-49558337	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 86.9;pituitary gland: 25.0"	"Cell type enhanced"	"Detected in some"		"Ciliated cells: 12.6;Excitatory neurons: 56.3;Inhibitory neurons: 18.5;Late spermatids: 10.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Uterine Corpus Endometrial Carcinoma (TCGA): 6.4"	"Group enriched"	"Detected in all"	6	"amygdala: 74.5;basal ganglia: 55.7;cerebral cortex: 82.6;hippocampal formation: 75.7;white matter: 63.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 5.5"	"Lung - Respiratory ciliated cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"							"unprognostic (2.01e-2)"	"unprognostic (4.08e-2)"			"unprognostic (9.71e-2)"	"unprognostic (1.20e-1)"												"unprognostic (1.25e-1)"	"unprognostic (2.69e-1)"									"unprognostic (9.35e-2)"	"unprognostic (2.08e-1)"
KCNH4	"elk1, Kv12.3"	ENSG00000089558	"Potassium voltage-gated channel subfamily H member 4"	Q9UQ05	17	42156891-42181142	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"brain: 7.2"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 6.5"	"Group enriched"	"Detected in many"	5	"eccentric medium spiny neuron: 65.1;medium spiny neuron: 116.1;upper-layer intratelencephalic: 31.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 33.1;cerebral cortex: 9.7;thalamus: 8.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 3.5;Neuroblastoma: 6.6"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"																																			
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3;retina: 4.3"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 47.3;Excitatory neurons: 178.8;Horizontal cells: 51.0;Inhibitory neurons: 71.0;Oligodendrocyte precursor cells: 61.8"	"Cell type enhanced"	"Detected in all"		"thalamic excitatory: 525.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 1.4;cervical cancer: 1.2"	"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol			NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	1	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "								"unprognostic (1.56e-1)"																							
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.7;kidney: 6.8;pituitary gland: 5.2;prostate: 3.8;retina: 4.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 42.1;Cone photoreceptor cells: 11.9;Enteroendocrine cells: 27.3;Horizontal cells: 11.3;Prostatic glandular cells: 24.5;Proximal enterocytes: 40.9"	"Cell type enhanced"	"Detected in many"		"mammillary body: 6.3;splatter: 5.7"	"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 8.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 6.2;lung cancer: 9.7;prostate cancer: 5.3"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pancreas - Alpha cells, Pituitary gland - Corticotropes, Prostate - Prostate glandular cells, Stomach - Gastric enteroendocrine cells, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.4;olfactory bulb: 3.2;spinal cord: 3.2"	HPA061704	Approved						NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 22: Proximal enterocytes - Digestion"				"HPA061704: "	"unprognostic (1.22e-2)"										"unprognostic (3.70e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.56e-2)"				"unprognostic (1.92e-2)"					"potential prognostic favorable (4.51e-4)"		"unprognostic (3.49e-1)"					"unprognostic (3.10e-1)"		
KCNH7	"erg3, HERG3, Kv11.3"	ENSG00000184611	"Potassium voltage-gated channel subfamily H member 7"	Q9NS40	2	162371407-162838767	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.4;retina: 1.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 663.4;Inhibitory neurons: 337.4"	"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.0"	"Lung - Neutrophil_2, Pituitary gland - Corticotropes, Spleen - Neutrophils, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"amygdala: 21.6;cerebral cortex: 85.1;hippocampal formation: 55.9;olfactory bulb: 53.9"	HPA018039	Uncertain						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 53: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"				"HPA018039: AB_1852125"								"unprognostic (4.19e-3)"																							
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148510-19535642	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.3;pituitary gland: 10.4;retina: 3.3"	"Group enriched"	"Detected in many"	39	"Oligodendrocyte precursor cells: 311.3;Oligodendrocytes: 921.0"	"Group enriched"	"Detected in many"	9	"committed oligodendrocyte precursor: 514.5;oligodendrocyte: 1153.5;oligodendrocyte precursor cell: 520.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.4"	"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 4.0;Neuroblastoma: 2.4"	"Colon - Enteric glia cells, Skin - Outer root sheath cells, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 11: White matter - Signal transduction"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 51: Oligodendrocytes - Unknown function"		"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "			"unprognostic (6.89e-2)"		"unprognostic (2.26e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"														"unprognostic (1.38e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.07e-2)"					
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"kidney: 191.1"	"Group enriched"	"Detected in some"	96	"Collecting duct cells: 23.3;Distal tubular cells: 79.9"	"Cell type enhanced"	"Detected in many"		"amygdala excitatory: 6.9;medium spiny neuron: 9.6"	"Group enriched"	"Detected in some"	7	"Kidney Chromophobe (TCGA): 34.1;Kidney Renal Papillary Cell Carcinoma (TCGA): 14.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Ascending Loop of Henle cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced						NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 33: Neurons - Mixed function"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	3			"HPA026962: AB_10601934"										"unprognostic (2.21e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.99e-1)"				"unprognostic (4.10e-1)"													"unprognostic (1.42e-1)"	
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 113.7;kidney: 27.0;retina: 35.6"	"Group enriched"	"Detected in some"	7	"Astrocytes: 88.2;Muller glia cells: 66.1;Oligodendrocyte precursor cells: 33.5;Oligodendrocytes: 87.3"	"Group enriched"	"Detected in many"	16	"astrocyte: 115.7;bergmann glia: 102.9;committed oligodendrocyte precursor: 69.0;ependymal cell: 35.9;oligodendrocyte: 141.2;oligodendrocyte precursor cell: 67.7"	"Cancer enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 42.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"skin cancer: 2.0"	"Kidney - Ascending Loop of Henle cells, Liver - Kupffer cells, Spleen - Macrophages, Stomach - Parietal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced						NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 10: Muller glia cells - Visual perception"	10			"HPA078302: AB_2732378"			"unprognostic (1.18e-1)"			"unprognostic (2.22e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.34e-1)"		"unprognostic (8.30e-2)"							"unprognostic (2.23e-1)"		"unprognostic (5.43e-2)"							"unprognostic (5.48e-2)"	"unprognostic (1.49e-1)"		"unprognostic (2.96e-1)"		
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium inwardly rectifying channel subfamily J member 11"	Q14654	11	17365172-17389331	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 129.9;tongue: 41.5"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 7.8;Cardiomyocytes: 19.5;Enteroendocrine cells: 6.3;Inhibitory neurons: 5.7;Skeletal myocytes: 13.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Cardiomyocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048891	Approved						NA	NA				"Cluster 79: Non-specific - Transcription"	"Cluster 37: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 68: Cardiomyocytes - Muscle contraction"	3			"HPA048891: AB_2680547"	"unprognostic (2.43e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.16e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.69e-1)"	"potential prognostic unfavorable (8.17e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.25e-3)"	"unprognostic (9.06e-2)"	"unprognostic (4.62e-3)"	"unprognostic (6.18e-2)"	"unprognostic (4.41e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.33e-2)"		"unprognostic (2.69e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.00e-1)"
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 41.5;skeletal muscle: 66.7;tongue: 24.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.2;Horizontal cells: 30.2;Muller glia cells: 9.1;Skeletal myocytes: 19.5"	"Cell type enhanced"	"Detected in many"		"upper rhombic lip: 44.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 58.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Fibroblasts, Skeletal muscle - Skeletal myocytes"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"			NA	NA				"Cluster 79: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	13	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"			"unprognostic (1.01e-3)"	"unprognostic (2.04e-1)"					"unprognostic (3.70e-2)"				"unprognostic (5.14e-3)"							"unprognostic (4.92e-2)"	"unprognostic (1.56e-1)"						"unprognostic (2.78e-3)"		"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.21e-2)"
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium inwardly rectifying channel subfamily J member 13"	O60928	2	232765802-232776565	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 170.7;intestine: 88.7"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 29.2;Muller glia cells: 52.0;Proximal enterocytes: 219.0;Undifferentiated cells: 65.7"	"Cell type enriched"	"Detected in all"	31	"choroid plexus epithelial cell: 238.7"	"Group enriched"	"Detected in some"	5	"Kidney Chromophobe (TCGA): 4.1;Kidney Renal Papillary Cell Carcinoma (TCGA): 3.8;Skin Cuteneous Melanoma (TCGA): 12.0"	"Region enriched"	"Detected in all"	15	"choroid plexus: 342.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"Kidney cancer: 1.1"	"Stomach - Parietal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane,Plasma membrane"			NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 22: Proximal enterocytes - Digestion"		"Nuclear membrane"	"Plasma membrane"	"HPA051609: "						"unprognostic (1.97e-2)"				"unprognostic (3.23e-2)"		"unprognostic (2.59e-1)"	"unprognostic (8.71e-2)"										"unprognostic (4.82e-2)"			"unprognostic (2.75e-3)"	"unprognostic (6.18e-3)"			"unprognostic (2.20e-2)"	
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium inwardly rectifying channel subfamily J member 14"	Q9UNX9	19	48455574-48466980	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 56.9"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 308.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 66: Photoreceptor cells - Visual perception"					"unprognostic (1.06e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.84e-3)"	"potential prognostic unfavorable (1.04e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-3)"		"unprognostic (1.65e-2)"			"unprognostic (1.39e-2)"					"unprognostic (7.81e-3)"		"unprognostic (5.88e-2)"		"unprognostic (6.69e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-2)"		"unprognostic (7.93e-2)"
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 232.9;thyroid gland: 125.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 86.7;Cholangiocytes: 87.8;Early spermatids: 141.5;Late spermatids: 77.7;Proximal tubular cells: 198.6"	"Cell type enhanced"	"Detected in some"		"deep-layer near-projecting: 1.5;fibroblast: 1.2;hippocampal CA1-3: 1.1"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 102.3;Thyroid Carcinoma (TCGA): 124.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"neutrophil: 398.0"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 398.0"	"Cancer enhanced"	"Detected in many"		"Bladder cancer: 22.2;head and neck cancer: 20.7"	"Adrenal gland - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Prostate - Urothelial cells, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	3	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (2.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.52e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.25e-1)"			"unprognostic (1.56e-3)"	"unprognostic (8.50e-2)"	"validated prognostic favorable (1.05e-11)"	"validated prognostic favorable (2.35e-4)"	"potential prognostic favorable (1.28e-4)"		"unprognostic (1.65e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-2)"	"potential prognostic unfavorable (5.68e-4)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.54e-3)"
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 188.3;parathyroid gland: 258.5;thyroid gland: 135.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 29.2;Cholangiocytes: 45.8;Collecting duct cells: 196.4;Distal tubular cells: 43.0;Oligodendrocyte precursor cells: 51.4;Proximal tubular cells: 87.4"	"Group enriched"	"Detected in many"	4	"astrocyte: 74.6;bergmann glia: 224.9;ependymal cell: 117.0;oligodendrocyte precursor cell: 101.0"	"Group enriched"	"Detected in many"	7	"Kidney Renal Clear Cell Carcinoma (TCGA): 68.8;Kidney Renal Papillary Cell Carcinoma (TCGA): 148.5;Thyroid Carcinoma (TCGA): 191.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 26.7;Sarcoma: 16.6"	"Lung - Respiratory ciliated cells, Minor Salivary Gland - Minor salivary gland ductal cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles			NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	2	Vesicles		"HPA059563: AB_2684065"			"unprognostic (2.08e-1)"			"unprognostic (4.43e-3)"	"unprognostic (4.98e-2)"	"unprognostic (9.26e-3)"		"unprognostic (1.90e-2)"	"potential prognostic favorable (6.16e-7)"	"unprognostic (1.39e-1)"	"potential prognostic favorable (1.77e-5)"	"unprognostic (8.04e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.04e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.03e-2)"			"unprognostic (2.52e-1)"		"unprognostic (1.88e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.76e-1)"
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 34.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 36.3;Horizontal cells: 61.1;monocytes: 61.8;Oligodendrocytes: 153.3;Skeletal myocytes: 36.1"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 237.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.7"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 11.3"	"Liver - Kupffer cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved						NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	10			"HPA029109: AB_10602913"	"unprognostic (3.15e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.45e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.72e-1)"		"unprognostic (1.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.12e-2)"
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.5"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 299.2;Inhibitory neurons: 413.7"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.9"	"Adipose subcutaneous - Smooth muscle cells, Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 8: Neurons - Neuronal signaling"	2	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "		"unprognostic (1.63e-1)"	"unprognostic (2.04e-1)"		"unprognostic (7.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"		"unprognostic (2.23e-1)"	"potential prognostic favorable (8.20e-9)"	"unprognostic (9.44e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-1)"					"unprognostic (9.15e-2)"		"unprognostic (1.02e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.27e-3)"		"unprognostic (2.30e-1)"			"unprognostic (1.04e-1)"
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium inwardly rectifying channel subfamily J member 4"	P48050	22	38426327-38455199	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"brain: 84.9;heart muscle: 32.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 13.8;Horizontal cells: 7.6;Inhibitory neurons: 10.6;Microglial cells: 3.6;Muller glia cells: 7.3;Sertoli cells: 2.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 3.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 2.4;Liver Hepatocellular Carcinoma (TCGA): 2.5;Uterine Corpus Endometrial Carcinoma (TCGA): 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 3.3"	"Adipose visceral - Mesothelial cells, Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"amygdala: 29.3;basal ganglia: 68.9;cerebral cortex: 74.2;hippocampal formation: 61.3;olfactory bulb: 76.3"								NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 8: Neurons - Neuronal signaling"	9										"unprognostic (7.27e-2)"	"unprognostic (4.18e-1)"				"unprognostic (2.14e-2)"	"unprognostic (9.62e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-3)"																"unprognostic (1.76e-2)"
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 62.3;pancreas: 19.8"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 54.8;Hofbauer cells: 43.7"	"Group enriched"	"Detected in many"	5	"central nervous system macrophage: 31.9;MGE interneuron: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adrenal gland - Adrenal cortex cells, Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes, Skin - Fibroblast_1"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved						NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 44: Non-specific - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	4			"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-2)"		"unprognostic (7.63e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.52e-3)"	"potential prognostic favorable (6.61e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"potential prognostic favorable (4.92e-4)"	"unprognostic (1.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"		"unprognostic (1.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.15e-1)"
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium inwardly rectifying channel subfamily J member 6"	P48051	21	37607373-38121345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;pituitary gland: 1.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 30.0;Enteroendocrine cells: 28.5;Excitatory neurons: 147.5;Horizontal cells: 99.5;Inhibitory neurons: 140.3;Oligodendrocyte precursor cells: 35.8"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in single"		"Testicular Germ Cell Tumor (TCGA): 1.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0;eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 2.0"	"Cancer enhanced"	"Detected in some"		"Sarcoma: 2.1"	"Adrenal gland - Adrenal medulla cells, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 1: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 8: Neurons - Neuronal signaling"	52						"unprognostic (2.09e-1)"					"unprognostic (6.98e-2)"																		"unprognostic (2.29e-2)"			"unprognostic (1.44e-1)"		
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 20.2;Cardiomyocytes: 24.1;Granulosa cells: 19.5;Hepatocytes: 22.8;Muller glia cells: 20.3;Sertoli cells: 73.4;Smooth muscle cells: 45.7"	"Cell type enriched"	"Detected in many"	5	"pericyte: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 6.8;liver cancer: 7.0;Neuroblastoma: 11.5"	"Breast - Endothelial cells, Kidney - Fibroblasts, Minor Salivary Gland - Endothelial cells, Skin - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain						NA	NA				"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 48: Smooth muscle cells - Signal transduction"	3			"HPA031066: AB_10602240"	"unprognostic (1.58e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.04e-1)"		"unprognostic (9.85e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.98e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.05e-1)"	"potential prognostic unfavorable (7.44e-4)"	"unprognostic (1.22e-1)"
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium inwardly rectifying channel subfamily J member 9"	Q92806	1	160081538-160090563	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 72.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.4;Excitatory neurons: 22.7;Horizontal cells: 15.7;Inhibitory neurons: 12.0;Oligodendrocytes: 7.7"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	47	"Glioblastoma Multiforme (TCGA): 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"Neuroblastoma: 3.6"	"Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 34: Non-specific - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	1			"HPA070478: AB_2686270"							"unprognostic (1.46e-1)"	"potential prognostic favorable (4.43e-5)"																							
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614106-233672514	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.9;choroid plexus: 72.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 152.6"	"Cell type enhanced"	"Detected in all"		"upper rhombic lip: 616.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	70	"plasmacytoid DC: 6.9"	"Lineage enriched"	"Detected in single"	70	"dendritic cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Skin - Keratinocyte (other), Stomach - Gastric mucous cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 160.5"	"HPA016049, CAB022588"	Approved		Approved	Vesicles			NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 5: Non-specific - Mixed function"	"Cluster 20: Myeloma - Immune response"	"Cluster 37: Glandular & Luminal cells - Unknown function"	52	Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (2.11e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"potential prognostic unfavorable (5.42e-4)"	"potential prognostic unfavorable (2.05e-5)"	"unprognostic (1.02e-3)"	"unprognostic (4.84e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.64e-1)"	"potential prognostic unfavorable (1.18e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.13e-1)"
KCNK12	"K2p12.1, THIK-2, THIK2"	ENSG00000184261	"Potassium two pore domain channel subfamily K member 12"	Q9HB15	2	47509290-47570985	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.9;Excitatory neurons: 18.3;Extravillous trophoblasts: 40.0;Inhibitory neurons: 29.1;Oocytes: 14.7;Rod photoreceptor cells: 12.1"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in single"	7	"Testicular Germ Cell Tumor (TCGA): 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Leukemia: 2.5;lymphoma: 1.7;Myeloma: 1.6"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 65: Neurons - Synaptic function"							"unprognostic (1.59e-1)"					"potential prognostic favorable (3.56e-5)"																					"unprognostic (5.07e-2)"		
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061994-90185853	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 4.3;parathyroid gland: 5.8;testis: 9.0"	"Cell type enriched"	"Detected in some"	4	"Microglial cells: 39.4"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 330.9;choroid plexus epithelial cell: 190.5"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 8.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 2.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Spleen - Macrophages, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"			NA	NA			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 14: Langerhans cells - Innate immune response"		"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (2.50e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.11e-1)"				"unprognostic (2.32e-1)"	"unprognostic (2.72e-2)"		"unprognostic (1.63e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.56e-2)"			"unprognostic (2.93e-1)"	"potential prognostic unfavorable (9.35e-4)"	"unprognostic (5.92e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.39e-1)"									"unprognostic (4.54e-2)"	"unprognostic (3.09e-1)"	
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745865-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Mesothelial cells: 43.8;Secretory cells: 104.5"	"Cell type enhanced"	"Detected in some"		"mammillary body: 4.6"	"Cancer enriched"	"Detected in many"	5	"Ovary Serous Cystadenocarcinoma (TCGA): 64.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Neutrophils"	"Region enriched"	"Detected in single"	18	"olfactory bulb: 6.8"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 5.1"	HPA064861	Uncertain						NA	NA				"Cluster 74: Spermatids - Flagellum assembly"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 37: Glandular & Luminal cells - Unknown function"				"HPA064861: AB_2685373"	"unprognostic (1.58e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.63e-3)"		"unprognostic (8.06e-3)"				"unprognostic (1.22e-1)"			"unprognostic (4.74e-2)"			"unprognostic (2.52e-1)"				"potential prognostic unfavorable (9.35e-4)"	"unprognostic (3.32e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.72e-2)"			"unprognostic (1.03e-1)"	"unprognostic (1.15e-1)"		"unprognostic (6.22e-3)"	"unprognostic (1.43e-1)"
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pancreas: 22.9;stomach 1: 10.1"	"Cell type enriched"	"Detected in some"	11	"Pancreatic endocrine cells: 13.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	16	"Pancreatic Adenocarcinoma (TCGA): 29.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 10.8"	"Pancreas - Alpha cells, Pancreas - Beta cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 15: Pancreas - Proteolysis"		"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	1																									"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"							"unprognostic (3.34e-1)"	
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.5;thyroid gland: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 35.1;Microglial cells: 17.0;Pancreatic endocrine cells: 18.7;Smooth muscle cells: 6.6"	"Cell type enriched"	"Detected in some"	21	"fibroblast: 115.2"	"Cancer enhanced"	"Detected in many"		"Thyroid Carcinoma (TCGA): 4.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.9"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 5.6;thyroid cancer: 3.4"	"Colon - Colon enteroendocrine cells"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 28: Dendritic cells - Antigen presentation"		"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"		"unprognostic (1.22e-2)"	"unprognostic (2.36e-1)"								"potential prognostic unfavorable (1.22e-4)"	"unprognostic (2.30e-2)"			"potential prognostic favorable (4.33e-4)"	"potential prognostic favorable (4.67e-5)"	"unprognostic (2.58e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.08e-2)"			"unprognostic (8.90e-3)"	"unprognostic (7.89e-2)"			"unprognostic (3.70e-2)"				"unprognostic (2.14e-1)"	"unprognostic (1.35e-1)"
KCNK18	"K2p18.1, TRESK, TRESK-2, TRESK2, TRIK"	ENSG00000186795	"Potassium two pore domain channel subfamily K member 18"	Q7Z418	10	117197489-117210299	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"choroid plexus: 2.9;hypothalamus: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"							HPA044739	Uncertain						NA	NA					"Cluster 36: Choroid plexus - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 11: Late spermatids - Unknown function"				"HPA044739: AB_10795008"																															
KCNK2	"K2p2.1, TREK-1"	ENSG00000082482	"Potassium two pore domain channel subfamily K member 2"	O95069	1	215005775-215237090	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"adrenal gland: 51.4"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 19.0;Inhibitory neurons: 51.6;Microglial cells: 28.6;Oligodendrocyte precursor cells: 42.9"	"Cell type enriched"	"Detected in many"	4	"fibroblast: 583.5"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"breast cancer: 13.3"	"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 33: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 69: Neurons - Neuronal signaling"						"unprognostic (3.26e-2)"	"unprognostic (4.77e-2)"				"unprognostic (8.84e-2)"	"unprognostic (6.62e-3)"			"unprognostic (9.11e-2)"	"unprognostic (2.91e-1)"						"unprognostic (1.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.87e-2)"				"unprognostic (1.70e-3)"			"unprognostic (1.20e-2)"	"unprognostic (3.75e-3)"
KCNK3	"K2p3.1, TASK, TASK-1, TASK1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692722-26733420	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 170.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 67.1;Collecting duct cells: 103.1;Enteroendocrine cells: 28.1;Exocrine glandular cells: 78.8;Smooth muscle cells: 30.4"	"Cell type enhanced"	"Detected in many"		"midbrain-derived inhibitory: 48.5;pericyte: 66.0"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 21.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 11.5;thyroid cancer: 10.3"	"Adrenal gland - Adrenal cortex cells, Pituitary gland - Gonadotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 48: Smooth muscle cells - Signal transduction"	5				"unprognostic (1.86e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.69e-2)"			"unprognostic (2.60e-1)"	"potential prognostic favorable (1.28e-5)"			"unprognostic (5.89e-3)"	"potential prognostic favorable (8.89e-4)"	"potential prognostic unfavorable (3.10e-4)"			"unprognostic (1.71e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.22e-1)"		"unprognostic (3.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.26e-3)"		"unprognostic (3.17e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.57e-2)"
KCNK4	"K2p4.1, TRAAK"	ENSG00000182450	"Potassium two pore domain channel subfamily K member 4"	Q9NYG8	11	64291302-64300031	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"brain: 13.4"	"Group enriched"	"Detected in some"	5	"Astrocytes: 2.8;Excitatory neurons: 8.7;Inhibitory neurons: 2.3"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 34: Neurons - Neuronal signaling"																																			
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.4;kidney: 36.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 53.4;Cytotrophoblasts: 28.2;Distal enterocytes: 43.4;Proximal enterocytes: 55.6;Salivary duct cells: 34.9;Syncytiotrophoblasts: 40.5"	"Cell type enhanced"	"Detected in some"		"fibroblast: 1.5;leukocyte: 1.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland ductal cells, Skin - Eccrine sweat gland cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm			NA	NA				"Cluster 55: Kidney & Intestine - Metabolism"		"Cluster 47: Leukemia - Hemostasis"	"Cluster 5: Enterocytes - Absorption"	24	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (6.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (3.95e-3)"	"unprognostic (1.40e-2)"	"unprognostic (5.17e-3)"	"validated prognostic favorable (3.54e-9)"	"validated prognostic favorable (1.63e-10)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.88e-1)"	"potential prognostic unfavorable (6.49e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.83e-3)"	"unprognostic (8.57e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.90e-2)"
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 130.8;Suprabasal keratinocytes: 138.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.3;granulocytes: 26.2;monocytes: 7.2"	"Low cancer specificity"	"Detected in many"			"Adrenal gland - Endothelial cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"			NA	NA			"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 6: Non-specific - Immune response"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 12: Squamous epithelial cells - Keratinization"		"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (1.80e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.76e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.16e-3)"
KCNK7	K2p7.1	ENSG00000173338	"Potassium two pore domain channel subfamily K member 7"	Q9Y2U2	11	65592836-65595996	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 87.3"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 128.1"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in many"		"Head and Neck Squamous Cell Carcinoma (TCGA): 11.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"basophil: 2.1;naive B-cell: 2.2;neutrophil: 1.5"	"Group enriched"	"Detected in many"	16	"B-cells: 2.2;granulocytes: 2.1"	"Cancer enhanced"	"Detected in some"		"Esophageal cancer: 2.9"	"Minor Salivary Gland - Minor salivary gland basal cells, Skin - Keratinocyte (other)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077577			Approved	"Plasma membrane"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 13: Skin - Cornification"	"Cluster 6: Non-specific - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 59: Suprabasal keratinocytes - Cornification"		"Plasma membrane"		"HPA077577: AB_2686845"	"unprognostic (4.82e-3)"		"unprognostic (1.01e-1)"	"unprognostic (8.86e-2)"			"unprognostic (3.91e-2)"		"unprognostic (1.82e-1)"				"unprognostic (1.22e-1)"					"unprognostic (4.75e-2)"				"unprognostic (9.01e-2)"			"unprognostic (3.42e-3)"		"unprognostic (2.68e-1)"				"unprognostic (5.68e-2)"
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139704109	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 9.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Horizontal cells: 10.7;Inhibitory neurons: 7.6;Late spermatids: 9.2;Oocytes: 51.5"	"Cell type enhanced"	"Detected in many"		"mammillary body: 53.4;upper rhombic lip: 107.4"	"Cancer enriched"	"Detected in single"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 2.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 1.1;thyroid cancer: 1.6"	"Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075842			Approved	"Plasma membrane"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 44: Oocytes - Unknown function"		"Plasma membrane"		"HPA075842: "								"unprognostic (2.64e-2)"			"unprognostic (5.11e-3)"	"unprognostic (1.34e-1)"									"unprognostic (2.85e-1)"		"unprognostic (1.91e-1)"								
KCNMA1	"KCa1.1, mSLO1, SLO"	ENSG00000156113	"Potassium calcium-activated channel subfamily M alpha 1"	Q12791	10	76869601-77638369	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 134.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 446.8;Bipolar cells: 485.5;Excitatory neurons: 989.5;Inhibitory neurons: 610.3;Oligodendrocyte precursor cells: 664.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5;non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Prostate - Smooth muscle cells, Spleen - Macrophages, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054648	Approved						NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 34: Neurons - Neuronal signaling"	2			"HPA054648: AB_2682556"	"unprognostic (3.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.35e-1)"	"unprognostic (4.26e-1)"	"potential prognostic favorable (7.57e-5)"	"unprognostic (2.38e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.27e-1)"	"unprognostic (5.40e-3)"	"potential prognostic favorable (7.51e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (9.29e-2)"	"potential prognostic unfavorable (6.61e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.05e-2)"
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000085	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 106.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 12.4;Langerhans cells: 18.1"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 16.2"	"Pituitary gland - Undifferentiated cells (Pituitary gland), Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"			Yes	No				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 28: Dendritic cells - Antigen presentation"		"Actin filaments, Cytosol"		"HPA065938: AB_2685582"			"unprognostic (7.84e-2)"				"unprognostic (2.36e-1)"	"unprognostic (4.00e-1)"		"unprognostic (1.00e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.80e-1)"							"unprognostic (2.47e-1)"									"unprognostic (1.62e-1)"		"unprognostic (2.95e-1)"
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Dystonia, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.1;liver: 31.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.4;Excitatory neurons: 145.1;Inhibitory neurons: 93.0;Oligodendrocyte precursor cells: 59.4;Prostatic glandular cells: 30.0"	"Cell type enhanced"	"Detected in all"		"hippocampal CA1-3: 649.6"	"Group enriched"	"Detected in many"	7	"Glioblastoma Multiforme (TCGA): 10.7;Prostate Adenocarcinoma (TCGA): 37.2;Skin Cuteneous Melanoma (TCGA): 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"prostate cancer: 28.6;skin cancer: 8.3"	"Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 29: Forebrain - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 65: Neurons - Synaptic function"	1	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (1.94e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.37e-1)"			"unprognostic (9.59e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.82e-1)"			"potential prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"		"unprognostic (9.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.47e-2)"			"unprognostic (8.82e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.36e-2)"		"unprognostic (6.18e-2)"	"unprognostic (3.25e-2)"		"unprognostic (1.76e-1)"		"unprognostic (1.50e-1)"
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.1;Ciliated cells: 28.9;Lymphatic endothelial cells: 51.8;Plasma cells: 40.5;Skeletal myocytes: 84.9"	"Cell type enhanced"	"Detected in all"		"astrocyte: 617.3;ependymal cell: 350.8"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 10.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Group enriched"	"Detected in some"	5	"lymphoma: 18.8;Myeloma: 37.2"	"Adipose subcutaneous - Smooth muscle cells, Colon - Enteric glia cells, Heart muscle - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017990, HPA057127"	Enhanced		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"		"Plasma membrane, Cytosol"		"HPA017990: AB_2669730, HPA057127: AB_2683345"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.06e-1)"	"unprognostic (1.29e-1)"	"potential prognostic favorable (4.11e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"validated prognostic favorable (1.10e-8)"	"validated prognostic favorable (7.85e-6)"				"unprognostic (9.14e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.40e-3)"		"unprognostic (2.64e-3)"	"unprognostic (1.49e-2)"			"unprognostic (3.86e-2)"		"unprognostic (6.89e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.47e-2)"
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43780976	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 122.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 223.3;Syncytiotrophoblasts: 783.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 11.0;leukocyte: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Breast - Breast glandular cells (progenitors), Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells, Spleen - B-cells (Spleen), Stomach - Gastric mucous cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA013367, HPA053841, HPA059622"	Approved		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 48: Stomach - Proteolysis"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	40	"Plasma membrane, Cytosol"		"HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (4.27e-3)"	"unprognostic (4.76e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.87e-2)"	"validated prognostic unfavorable (1.54e-5)"	"validated prognostic unfavorable (1.44e-4)"	"unprognostic (1.87e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.70e-1)"	"potential prognostic unfavorable (9.06e-5)"	"unprognostic (4.22e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.69e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.47e-3)"
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 191.0;stomach 1: 96.2"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 68.0"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 392.3"	"Cancer enhanced"	"Detected in all"		"Kidney Chromophobe (TCGA): 119.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 32.2;Gastric cancer: 20.3"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Parietal cells, Thyroid gland - Thyroid glandular cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011306, HPA048553, HPA071107"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"	9	"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA011306: , HPA048553: AB_2680438, HPA071107: "	"unprognostic (1.69e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"potential prognostic favorable (9.37e-5)"	"unprognostic (1.16e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.87e-3)"	"unprognostic (8.78e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-2)"
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400208-63472677	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 136.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 19.5;Excitatory neurons: 59.7;Horizontal cells: 30.2;Inhibitory neurons: 35.9;Oligodendrocyte precursor cells: 47.6;Spermatogonia: 31.1"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	10	"Glioblastoma Multiforme (TCGA): 38.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 18.5;Neuroblastoma: 51.2"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Beta cells, Pituitary gland - Thyrotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"			NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 51: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	2	"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"							"unprognostic (1.34e-1)"	"unprognostic (1.51e-2)"																"unprognostic (5.51e-2)"					"unprognostic (2.21e-1)"		"unprognostic (3.47e-2)"
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120859-132481095	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 16.1"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 484.5;Inhibitory neurons: 464.3;Microglial cells: 479.5"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 2585.5"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 5.0;Thyroid Carcinoma (TCGA): 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Colon - Colon enteroendocrine cells, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 65: Neurons - Synaptic function"	1					"unprognostic (2.08e-1)"	"unprognostic (1.12e-3)"				"unprognostic (3.22e-1)"	"unprognostic (6.14e-2)"			"unprognostic (2.55e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"			"unprognostic (5.54e-3)"	"unprognostic (8.75e-3)"		"unprognostic (1.34e-1)"			"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"							"unprognostic (9.82e-2)"	
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 5.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.9;Inhibitory neurons: 9.3;Muller glia cells: 3.4;Skeletal myocytes: 5.9;Smooth muscle cells: 3.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Prostate - Smooth muscle cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018305	Uncertain						NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 65: Neurons - Synaptic function"				"HPA018305: AB_1855556"			"unprognostic (3.66e-2)"			"unprognostic (3.11e-1)"		"unprognostic (1.87e-1)"												"unprognostic (1.55e-1)"	"unprognostic (1.88e-1)"		"unprognostic (4.57e-2)"			"unprognostic (2.22e-2)"		"unprognostic (1.23e-1)"			
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198853	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 15.7;tongue: 11.3"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 2066.7;Inhibitory neurons: 827.2"	"Cell type enhanced"	"Detected in all"		"lower rhombic lip: 5906.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Colon enteroendocrine cells, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Approved		Uncertain	"Cytoplasmic bodies"			NA	NA				"Cluster 54: Non-specific - Basic cellular processes"	"Cluster 24: Neurons - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 34: Neurons - Neuronal signaling"		"Cytoplasmic bodies"		"HPA016655: AB_1855557"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-1)"				"unprognostic (1.22e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-3)"							"unprognostic (2.05e-2)"	"potential prognostic unfavorable (2.65e-5)"	"unprognostic (4.10e-3)"	"unprognostic (2.60e-1)"								"unprognostic (1.15e-2)"			"unprognostic (3.45e-2)"	
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45091214-45101127	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 26.8"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 2.5;Cholangiocytes: 5.7;Excitatory neurons: 6.0"	"Cell type enhanced"	"Detected in some"		"upper-layer intratelencephalic: 6.1"	"Cancer enhanced"	"Detected in many"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 9.5"	"Region enhanced"	"Detected in all"		"cerebral cortex: 58.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cervical cancer: 11.4;thyroid cancer: 4.0"	"Pituitary gland - Gonadotropes, Skin - Keratinocyte (other), Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043351			Approved	"Nucleoplasm,Vesicles,Plasma membrane"			NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 4: Non-specific - Transcription"	"Cluster 34: Neurons - Neuronal signaling"		"Vesicles, Plasma membrane"	Nucleoplasm	"HPA043351: "	"unprognostic (5.30e-2)"			"unprognostic (5.09e-3)"			"unprognostic (6.35e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.14e-2)"		"potential prognostic unfavorable (2.09e-8)"	"unprognostic (2.30e-3)"	"unprognostic (1.21e-3)"							"potential prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.90e-1)"				"unprognostic (2.09e-1)"		"unprognostic (3.33e-1)"		
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98426958-98432853	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.1"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.9;Excitatory neurons: 4.3;Horizontal cells: 3.1;Inhibitory neurons: 1.6;Leydig cells: 1.4"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Kidney cancer: 1.3"	"Pituitary gland - Somatotropes, Spleen - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain						NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 9: Endometrial stromal cells - Transcription"	3			"HPA051417: AB_2681478"								"unprognostic (2.82e-1)"																							
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.0;tongue: 43.8"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 32.2"	"Cell type enhanced"	"Detected in many"		"committed oligodendrocyte precursor: 165.1;MGE interneuron: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Fibroblasts, Spleen - Fibroblast_1, Testis - Sertoli cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			NA	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 50: Connective tissue cells - ECM organization"		Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"potential prognostic favorable (6.40e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.63e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.32e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.17e-2)"
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 44.5;lymphoid tissue: 15.3;skeletal muscle: 12.9"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 58.0;Inhibitory neurons: 52.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"Ovary Serous Cystadenocarcinoma (TCGA): 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"Neuroblastoma: 5.6"	"Heart muscle - Cardiomyocytes, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 56.2"	"HPA059880, HPA060577"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 8: Neurons - Neuronal signaling"		"Plasma membrane"	Nucleoplasm	"HPA059880: AB_2684149, HPA060577: "								"unprognostic (1.44e-1)"												"potential prognostic unfavorable (1.39e-4)"	"unprognostic (1.99e-2)"										
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 3.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 212.4;Inhibitory neurons: 229.3;Oligodendrocyte precursor cells: 291.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 4.0"	"Adipose visceral - Mesothelial cells, Heart muscle - Fibroblasts, Prostate - Fibroblasts, Skin - Endothelial cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles			NA	NA				"Cluster 83: Liver - Metabolism"	"Cluster 14: Neurons - Synaptic function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"		Vesicles		"HPA051218: AB_2681392"			"unprognostic (3.32e-1)"				"unprognostic (6.79e-2)"	"potential prognostic favorable (2.67e-4)"				"unprognostic (1.90e-1)"	"unprognostic (8.72e-2)"		"unprognostic (9.08e-2)"								"unprognostic (1.37e-2)"								
KCNV1	Kv8.1	ENSG00000164794	"Potassium voltage-gated channel modifier subfamily V member 1"	Q6PIU1	8	109963636-109975771	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"brain: 13.1"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 27.3"	"Cell type enhanced"	"Detected in many"		"deep-layer intratelencephalic: 42.7;upper-layer intratelencephalic: 35.0"	"Cancer enriched"	"Detected in single"	4	"Kidney Renal Papillary Cell Carcinoma (TCGA): 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.5"	"Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 48.0"	HPA067233			Supported	"Plasma membrane,Cytokinetic bridge"			Yes	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 34: Neurons - Neuronal signaling"		"Plasma membrane, Cytokinetic bridge"		"HPA067233: "						"unprognostic (4.31e-3)"		"unprognostic (7.87e-2)"				"unprognostic (1.51e-2)"	"unprognostic (2.90e-1)"													"unprognostic (1.67e-1)"					
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717510-2730037	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"retina: 280.3"	"Group enriched"	"Detected in some"	10	"Cone photoreceptor cells: 1522.4;Rod photoreceptor cells: 472.1"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	90	"Testicular Germ Cell Tumor (TCGA): 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 33: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 66: Photoreceptor cells - Visual perception"	2			"HPA031131: AB_10609996"																													"unprognostic (4.00e-1)"		
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin TRP cation channel 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 101.6;Kupffer cells: 88.5;Macrophages: 74.1;monocytes: 78.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 118.2;classical monocyte: 45.3;eosinophil: 106.1;intermediate monocyte: 95.7;neutrophil: 41.4;non-classical monocyte: 105.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 118.2;monocytes: 105.7"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adrenal gland - Adrenal cortex cells, Lung - Macrophages, Prostate - Macrophages, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"			NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 47: Spleen - Immune response"	"Cluster 27: Non-specific - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 58: Macrophages - Innate immune response"	7	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (8.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.17e-1)"	"potential prognostic unfavorable (4.86e-4)"	"potential prognostic favorable (1.04e-6)"	"unprognostic (1.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-1)"	"potential prognostic favorable (4.11e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-1)"
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin TRP cation channel 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 8.5;intestine: 14.6;lymphoid tissue: 12.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 40.1;dendritic cells: 79.7;Early spermatids: 67.0;Glandular and luminal cells: 27.3;Langerhans cells: 114.9;Schwann cells: 32.0"	"Cell type enriched"	"Detected in many"	15	"leukocyte: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.6"	"Group enriched"	"Detected in many"	15	"B-cells: 10.3;dendritic cells: 29.6;T-cells: 8.8"	"Cancer enriched"	"Detected in many"	5	"lymphoma: 27.9"	"Adipose subcutaneous - T-cells, Liver - T-cells, Spleen - B-cells (Spleen), Testis - Early spermatids, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019114	Uncertain						NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	3			"HPA019114: AB_1853645"	"unprognostic (2.90e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.34e-3)"		"unprognostic (4.25e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.50e-2)"			"potential prognostic favorable (3.09e-5)"	"potential prognostic favorable (2.47e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-2)"		"unprognostic (4.48e-2)"
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin TRP cation channel 3"	Q8TDD5	1	85018082-85048500	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 42.4;epididymis: 13.8;parathyroid gland: 34.1"	"Group enriched"	"Detected in many"	6	"Enteroendocrine cells: 53.4;Melanocytes: 211.3"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 20.1;hippocampal dentate gyrus: 43.9"	"Cancer enhanced"	"Detected in many"		"Skin Cuteneous Melanoma (TCGA): 12.9"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 8.3;choroid plexus: 7.4;hippocampal formation: 7.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 12.1"	"Adrenal gland - Adrenal cortex cells, Lung - Fibroblast_1, Skeletal muscle - Fibroblasts"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory bulb: 1.2"	"HPA018106, HPA062137"	Enhanced						NA	NA				"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 29: Forebrain - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	2			"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (2.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.79e-2)"		"unprognostic (5.28e-2)"			"unprognostic (2.48e-3)"	"unprognostic (5.26e-3)"					"unprognostic (1.37e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.73e-3)"			"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"		"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 124.7;Inhibitory neurons: 142.7;Microglial cells: 91.3;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 204.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Lung - Fibroblast_1, Skin - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"	"Secreted - unknown location"	Transport	NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 11: White matter - Signal transduction"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	25	"Endoplasmic reticulum, Plasma membrane"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (6.97e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.57e-1)"	"unprognostic (9.98e-3)"	"validated prognostic favorable (1.63e-7)"	"validated prognostic favorable (4.33e-4)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288149-100330264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.7;retina: 12.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 10.3;Hofbauer cells: 13.7;Horizontal cells: 19.5;Kupffer cells: 9.7;Late spermatids: 21.6"	"Cell type enhanced"	"Detected in some"		"deep-layer intratelencephalic: 7.7;deep-layer near-projecting: 19.2"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 5.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 2.2;Uterine cancer: 1.0"	"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB022621, HPA070002"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 53: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 58: Macrophages - Innate immune response"	1	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB022621: , HPA070002: "		"unprognostic (9.32e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.14e-2)"	"unprognostic (9.85e-2)"			"unprognostic (8.19e-2)"	"unprognostic (2.58e-1)"	"potential prognostic favorable (9.09e-5)"	"unprognostic (3.75e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"			"unprognostic (1.08e-1)"							"unprognostic (1.57e-2)"		
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 7.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 58.8;Spermatocytes: 43.1"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Uterine Corpus Endometrial Carcinoma (TCGA): 5.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 78: Testis - Transcription"	"Cluster 34: Non-specific - Mixed function"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"		"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (1.74e-1)"			"unprognostic (3.92e-2)"		"unprognostic (2.11e-3)"				"potential prognostic unfavorable (1.36e-4)"			"unprognostic (1.78e-1)"		"unprognostic (5.91e-2)"								"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"		"unprognostic (1.16e-2)"			"unprognostic (3.46e-1)"		"unprognostic (2.31e-1)"
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696802-38816286	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040337			Approved	"Connecting piece,Flagellar centriole"			NA	NA						"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 21: Early spermatids - Spermatogenesis"		"Connecting piece, Flagellar centriole"		"HPA040337: "																															
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845764-39052157	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9;placenta: 1.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.0;Astrocytes: 7.4;Early spermatids: 7.6;Late spermatids: 5.0;Spermatocytes: 18.4;Spermatogonia: 12.0"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 60.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enteroendocrine cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036746, HPA036747"	Uncertain						NA	NA				"Cluster 47: Spleen - Immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 67: Spermatogonia - Spermatogenesis"				"HPA036746: AB_10696785, HPA036747: AB_2675287"			"unprognostic (2.52e-1)"																												
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;retina: 3.3"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 396.7;Inhibitory neurons: 474.6;Oligodendrocyte precursor cells: 649.5"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in single"	7	"Glioblastoma Multiforme (TCGA): 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enteroendocrine cells, Heart muscle - Cardiomyocytes, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 8: Neurons - Neuronal signaling"	1	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"							"unprognostic (4.38e-1)"	"unprognostic (7.03e-3)"																							
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 70.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 425.4;Inhibitory neurons: 349.2;Oligodendrocyte precursor cells: 231.1"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 5.8"	"Adipose visceral - Mesothelial cells, Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 14: Neurons - Synaptic function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"	4			"CAB022567: "			"unprognostic (5.41e-1)"				"unprognostic (3.49e-1)"	"unprognostic (1.29e-3)"		"unprognostic (1.74e-1)"			"unprognostic (1.38e-1)"						"unprognostic (1.99e-1)"				"unprognostic (1.25e-1)"								
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087526-165204050	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9;lymphoid tissue: 3.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.5;Excitatory neurons: 219.5;Inhibitory neurons: 161.8;Oligodendrocyte precursor cells: 336.3"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 3.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 13.3;naive B-cell: 15.4"	"Lineage enriched"	"Detected in single"	32	"B-cells: 15.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.7"	"Pituitary gland - Lactotropes, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Uncertain						NA	NA			"Cluster 34: B-cells - Unknown function"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 1: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	1			"HPA035396: AB_2674607"			"unprognostic (5.07e-3)"			"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"potential prognostic favorable (3.01e-4)"									"unprognostic (1.31e-2)"									"unprognostic (4.18e-1)"					
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 132.5;tongue: 51.9"	"Group enriched"	"Detected in some"	6	"Adipocytes: 40.2;Skeletal myocytes: 38.1"	"Cell type enriched"	"Detected in some"	27	"fibroblast: 36.6"	"Cancer enhanced"	"Detected in some"		"Thyroid Carcinoma (TCGA): 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Leukemia: 2.1;Sarcoma: 6.5"	"Pituitary gland - Somatotropes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	HPA070997			Uncertain	"Golgi apparatus"			NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"		"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"		"Golgi apparatus"		"HPA070997: "			"unprognostic (2.36e-3)"					"unprognostic (1.53e-1)"			"potential prognostic favorable (1.24e-7)"																		"unprognostic (3.10e-1)"	"unprognostic (3.59e-1)"	
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"heart muscle: 41.3"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 57.8;Cone photoreceptor cells: 34.0;Oocytes: 20.6"	"Cell type enhanced"	"Detected in many"		"eccentric medium spiny neuron: 37.8;fibroblast: 22.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 5.5;Sarcoma: 4.2"	"Breast - Breast myoepithelial cells, Colon - Colon enteroendocrine cells, Heart muscle - Cardiomyocytes, Pituitary gland - Undifferentiated cells (Pituitary gland)"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 6.6"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"			NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 68: Cardiomyocytes - Muscle contraction"	11	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.16e-2)"																												"unprognostic (1.53e-1)"		
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 17.5;pituitary gland: 6.5;retina: 7.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 325.4;Inhibitory neurons: 269.0;Oligodendrocyte precursor cells: 98.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 8: Neurons - Neuronal signaling"	1	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "			"unprognostic (1.37e-1)"			"unprognostic (2.40e-1)"	"unprognostic (7.00e-2)"	"potential prognostic favorable (2.44e-4)"					"unprognostic (7.21e-2)"		"unprognostic (8.57e-3)"		"unprognostic (3.78e-1)"		"potential prognostic favorable (3.92e-4)"	"unprognostic (1.68e-2)"			"unprognostic (2.49e-1)"			"unprognostic (2.75e-1)"		"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"		
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.7;Exocrine glandular cells: 52.7;Hofbauer cells: 65.0;Langerhans cells: 53.3;Lymphatic endothelial cells: 59.2;Oligodendrocyte precursor cells: 125.5;Schwann cells: 89.5;Sertoli cells: 73.4"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte precursor cell: 408.5"	"Cancer enhanced"	"Detected in some"		"Lung Squamous Cell Carcinoma (TCGA): 4.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 44.7"	"Kidney - Proximal tubular cells, Testis - Sertoli cells"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 44: Testis - Spermatogenesis"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 58: Macrophages - Innate immune response"		"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"			"unprognostic (3.00e-1)"			"unprognostic (1.04e-1)"		"unprognostic (5.89e-2)"	"unprognostic (1.14e-2)"		"unprognostic (2.70e-2)"	"unprognostic (7.62e-2)"			"unprognostic (2.59e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"			"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"			"unprognostic (1.78e-1)"					
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 165.3;Microglial cells: 76.0"	"Cell type enhanced"	"Detected in all"		"fibroblast: 439.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved						NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 25: Non-specific - Transcription"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 47: Astrocytes - Unknown function"	4			"HPA039757: AB_10795156"	"unprognostic (1.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.52e-3)"	"unprognostic (4.45e-1)"	"potential prognostic favorable (3.64e-4)"	"potential prognostic unfavorable (3.49e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-1)"	"potential prognostic unfavorable (5.13e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (2.78e-1)"	"unprognostic (8.79e-3)"
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048932-69136316	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 29.5;Inhibitory neurons: 21.5;Melanocytes: 41.2;Oligodendrocyte precursor cells: 24.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 24.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Stomach - Parietal cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 66: Non-specific - Transcription"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 24: Non-specific - Unknown function"	"Cluster 34: Neurons - Neuronal signaling"	3	Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (7.63e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.77e-3)"	"unprognostic (1.96e-3)"	"unprognostic (2.81e-1)"	"validated prognostic favorable (7.62e-6)"	"validated prognostic favorable (6.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.83e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.73e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-1)"
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075584	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport"	"Calcium channel, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.9;stomach 1: 10.0;urinary bladder: 26.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 16.0;Intestinal goblet cells: 31.9"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 14.5;pericyte: 10.3"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 7.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 7.2"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"										NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 16: Intestinal goblet cells - Mucin production"					"unprognostic (8.87e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.65e-1)"		"unprognostic (7.23e-3)"	"unprognostic (1.02e-1)"					"potential prognostic favorable (2.64e-5)"	"unprognostic (6.68e-2)"	"unprognostic (2.66e-2)"					"unprognostic (1.74e-2)"	"unprognostic (3.60e-2)"			"unprognostic (6.90e-2)"	"unprognostic (1.92e-1)"		"unprognostic (3.17e-2)"	"unprognostic (4.17e-2)"		"unprognostic (4.47e-2)"	"unprognostic (3.27e-1)"		
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724034-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 88.9;Excitatory neurons: 139.6;Inhibitory neurons: 176.7;Microglial cells: 47.4;Oligodendrocyte precursor cells: 145.3;Oligodendrocytes: 153.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatic stellate cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles			NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 37: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"	14	Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (4.45e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.96e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.58e-2)"		"potential prognostic unfavorable (6.02e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.35e-2)"	"unprognostic (9.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.21e-1)"		"potential prognostic favorable (5.96e-4)"	"unprognostic (6.20e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.39e-2)"	"potential prognostic unfavorable (9.75e-5)"
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121874481-121952060	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;pituitary gland: 7.2;retina: 3.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 30.6;Excitatory neurons: 17.5;Inhibitory neurons: 78.4;Oligodendrocyte precursor cells: 31.6;Rod photoreceptor cells: 52.3"	"Cell type enriched"	"Detected in many"	6	"pericyte: 950.2"	"Cancer enhanced"	"Detected in single"		"Kidney Chromophobe (TCGA): 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Breast - Endothelial cells, Testis - Spermatogonia"	"Region enhanced"	"Detected in all"		"cerebellum: 57.8"	"Low region specificity"	"Detected in all"										NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 65: Neurons - Synaptic function"	6						"unprognostic (6.57e-2)"					"potential prognostic favorable (2.30e-4)"		"unprognostic (3.67e-2)"																					
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37632063-37869802	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 11.5;seminal vesicle: 8.7;smooth muscle: 12.2"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 128.2"	"Cell type enhanced"	"Detected in many"		"hippocampal CA1-3: 411.7;pericyte: 396.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.8"	"Adipose subcutaneous - Smooth muscle cells, Skeletal muscle - Endothelial cells, Spleen - Smooth muscle cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 43.1"	"Low region specificity"	"Detected in all"										NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 14: Neurons - Synaptic function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 8: Neurons - Neuronal signaling"	6						"unprognostic (2.92e-1)"			"unprognostic (9.31e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"			"unprognostic (1.86e-3)"	"potential prognostic favorable (5.69e-4)"							"unprognostic (9.77e-3)"			"unprognostic (1.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"		"unprognostic (1.15e-1)"					
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111768011-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.4"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 44.6;Inhibitory neurons: 75.7;Oligodendrocytes: 35.6"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 372.8;midbrain-derived inhibitory: 346.7"	"Cancer enriched"	"Detected in single"	9	"Thyroid Carcinoma (TCGA): 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 1: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 8: Neurons - Neuronal signaling"	3											"unprognostic (8.15e-3)"																						"unprognostic (1.41e-2)"	
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.9;placenta: 20.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 45.0;Microglial cells: 11.6;Smooth muscle cells: 21.1"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 250.7"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.4;testis cancer: 1.9"	"Adipose subcutaneous - Endothelial cells, Minor Salivary Gland - Endothelial cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved						NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 58: Placenta - Pregnancy"	"Cluster 17: Choroid plexus - Cilium"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 69: Neurons - Neuronal signaling"	6			"HPA045098: AB_10959600"		"unprognostic (1.06e-1)"	"unprognostic (5.46e-2)"			"unprognostic (2.11e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.85e-2)"		"validated prognostic favorable (1.39e-5)"	"validated prognostic favorable (2.90e-5)"				"unprognostic (4.59e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.72e-2)"			"unprognostic (5.69e-2)"	"unprognostic (1.31e-2)"			"unprognostic (1.19e-1)"		"unprognostic (2.71e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.18e-2)"
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136212745-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Bipolar cells: 5.2;Enteroendocrine cells: 3.4;Inhibitory neurons: 9.7;Oocytes: 6.6;Proximal tubular cells: 5.4;Spermatocytes: 3.5"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 52.8;midbrain-derived inhibitory: 97.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal medulla cells, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain						NA	NA					"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 65: Neurons - Synaptic function"	1			"CAB022592: , HPA031126: AB_10603221"																															
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001065-31161160	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 17.0;skin 1: 4.7"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 579.2;Melanocytes: 226.8"	"Cell type enriched"	"Detected in some"	4	"oligodendrocyte: 62.9"	"Cancer enriched"	"Detected in single"	263	"Skin Cuteneous Melanoma (TCGA): 35.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	248	"skin cancer: 38.0"	"Adipose visceral - Adipocytes (Visceral), Skin - Melanocytes, Testis - Early spermatids"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"			NA	NA				"Cluster 39: Retina & Testis - Cilium"		"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 25: Bipolar cells - Visual perception"		"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "																											"unprognostic (4.56e-2)"				
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Cataract, Disease variant, Epilepsy, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"choroid plexus: 676.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 858.3;Excitatory neurons: 376.7;Inhibitory neurons: 179.3;Muller glia cells: 155.8;Oligodendrocyte precursor cells: 99.0"	"Cell type enriched"	"Detected in all"	4	"choroid plexus epithelial cell: 25353.9"	"Cancer enhanced"	"Detected in some"		"Kidney Renal Clear Cell Carcinoma (TCGA): 3.1;Kidney Renal Papillary Cell Carcinoma (TCGA): 3.7"	"Region enriched"	"Detected in all"	15	"choroid plexus: 1433.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 5.1;Rhabdoid: 10.6"	"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Pancreas - Beta cells, Prostate - Fibroblasts, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Uncertain	Vesicles			NA	NA				"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 34: Neurons - Neuronal signaling"		Vesicles		"HPA072650: , HPA074393: "							"unprognostic (8.52e-3)"	"unprognostic (1.97e-1)"			"potential prognostic favorable (1.03e-9)"	"unprognostic (1.07e-3)"	"potential prognostic favorable (1.52e-4)"										"unprognostic (5.71e-2)"						"unprognostic (1.08e-1)"		
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 183.0;Hepatocytes: 90.1;Intestinal goblet cells: 84.0;Prostatic glandular cells: 86.0"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"Prostate Adenocarcinoma (TCGA): 154.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Prostate - Prostate glandular cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 45: Intestine - Digestion"	"Cluster 12: Non-specific - Vasculature"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	9	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (4.49e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.02e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.45e-3)"	"potential prognostic favorable (4.08e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.52e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.60e-2)"	"unprognostic (9.68e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.30e-3)"	"unprognostic (4.07e-3)"	"unprognostic (5.87e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.45e-2)"	"unprognostic (3.45e-1)"	"potential prognostic unfavorable (3.17e-4)"	"unprognostic (2.77e-2)"
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2444514	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.7;intestine: 3.2;pancreas: 2.3"	"Cell type enriched"	"Detected in some"	42	"Oocytes: 76.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Pancreatic Adenocarcinoma (TCGA): 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.0"	"Colon - Colon enterocytes, Prostate - Urothelial cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 53: Non-specific - Glycosylation"		"Cluster 24: Non-specific - Unknown function"	"Cluster 44: Oocytes - Unknown function"	1									"unprognostic (2.90e-2)"																"unprognostic (2.37e-1)"				"unprognostic (8.37e-3)"					
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 16.0"	"Group enriched"	"Detected in some"	9	"Distal enterocytes: 76.8;Glandular and luminal cells: 27.8;Microglial cells: 37.6;Oligodendrocytes: 75.5;Proximal enterocytes: 19.3"	"Group enriched"	"Detected in many"	9	"endothelial cell: 369.5;oligodendrocyte: 117.3"	"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 4.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.2;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 23.2"	"Cancer enhanced"	"Detected in single"		"Gallbladder cancer: 2.9"	"Kidney - Intercalated cells, Skeletal muscle - Endothelial cells, Skin - Outer root sheath cells, Spleen - Neutrophils"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 45: Intestine - Digestion"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 5: Enterocytes - Absorption"							"unprognostic (1.44e-1)"		"unprognostic (4.39e-1)"	"unprognostic (5.32e-2)"		"unprognostic (9.62e-2)"		"unprognostic (1.25e-1)"													"unprognostic (3.10e-1)"		"potential prognostic favorable (2.86e-4)"	"unprognostic (1.66e-1)"			"unprognostic (1.92e-2)"		"unprognostic (8.36e-2)"
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 105.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 31: Non-specific - Transcription"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 34: Neurons - Neuronal signaling"	11	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (5.36e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.17e-3)"	"potential prognostic favorable (4.75e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917373-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"liver: 30.5;prostate: 77.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 37.5;Prostatic glandular cells: 87.1"	"Cell type enhanced"	"Detected in some"		"cerebellar inhibitory: 9.5"	"Cancer enriched"	"Detected in some"	35	"Prostate Adenocarcinoma (TCGA): 151.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Kidney cancer: 6.3;Myeloma: 7.1;prostate cancer: 13.1;skin cancer: 15.8"	"Prostate - Prostate glandular cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 46: Brainstem - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 40: Prostatic glandular cells - Transcription"	1										"unprognostic (1.09e-1)"	"unprognostic (3.28e-3)"					"unprognostic (5.52e-2)"	"validated prognostic favorable (3.92e-4)"	"validated prognostic favorable (6.18e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.13e-2)"						"potential prognostic unfavorable (8.66e-4)"	"unprognostic (2.98e-2)"			"unprognostic (5.16e-2)"				
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Oligodendrocytes: 17.5;Rod photoreceptor cells: 23.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"				"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 11: White matter - Signal transduction"	"Cluster 42: Non-specific - Unknown function"	"Cluster 66: Photoreceptor cells - Visual perception"	5				"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.28e-1)"		"unprognostic (1.84e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-3)"	"potential prognostic favorable (1.07e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.16e-2)"		"potential prognostic favorable (8.59e-5)"	"unprognostic (1.51e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.17e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-1)"
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783087-109833406	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease variant, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 71.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Cholangiocytes: 15.3;Ciliated cells: 18.7;Cytotrophoblasts: 19.4;Ionocytes: 19.1;Kupffer cells: 14.6;Salivary duct cells: 15.0;Serous glandular cells: 15.4;Syncytiotrophoblasts: 19.4"	"Cell type enriched"	"Detected in some"	38	"choroid plexus epithelial cell: 456.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"choroid plexus: 107.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 10.6"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Lung - Respiratory ciliated cells, Prostate - Prostate basal glandular cells, Skin - Eccrine sweat gland cells, Spleen - Macrophages, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	HPA007150	Uncertain						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 35: Respiratory epithelial cells - Unknown function"	2			"HPA007150: AB_1080393"	"unprognostic (1.18e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.11e-1)"			"unprognostic (1.40e-2)"	"unprognostic (1.54e-3)"	"potential prognostic favorable (4.70e-6)"	"unprognostic (8.75e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.95e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.36e-1)"		"unprognostic (2.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.01e-2)"
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933746	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 1.6;kidney: 4.3"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocytes: 14.1"	"Cell type enriched"	"Detected in some"	6	"oligodendrocyte: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Minor Salivary Gland - Minor salivary glandular cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063175	Uncertain						NA	NA				"Cluster 52: Kidney - Transmembrane transport"		"Cluster 66: Non-specific - Mitochondria"	"Cluster 51: Oligodendrocytes - Unknown function"	2			"HPA063175: AB_2684954"																															
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871208-142885745	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 37.2;prostate: 22.7;salivary gland: 67.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 90.1;Exocrine glandular cells: 22.6;Late spermatids: 40.9;Prostatic glandular cells: 53.4;Serous glandular cells: 68.3"	"Cell type enriched"	"Detected in some"	6	"oligodendrocyte: 10.1"	"Cancer enriched"	"Detected in many"	6	"Prostate Adenocarcinoma (TCGA): 52.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 7.9;prostate cancer: 11.5"	"Adipose visceral - Mesothelial cells, Liver - Cholangiocyte, Prostate - Prostate glandular cells, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA062864	Approved						NA	NA				"Cluster 38: Salivary gland - Salivary secretion"		"Cluster 60: Prostate cancer - Unknown function"	"Cluster 75: Serous glandular cells - Salivary secretion"	4			"HPA062864: AB_2684885"	"unprognostic (2.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.72e-2)"						"unprognostic (7.08e-3)"					"unprognostic (2.73e-1)"					"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.74e-1)"				"unprognostic (1.08e-2)"			"unprognostic (1.61e-1)"
